From: The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
KEGG ID & description
Target
False discovery rate
hsa04917: prolactin signaling pathway
ESR1, ESR2, GSK3B
0.0134
hsa04660: T cell receptor signaling pathway
FYN, IL2, GSK3B
0.0267
hsa04151: PI3K-Akt signaling pathway
VEGFA, IL2, GSK3B, NR4A1
0.0450